-
Telik Posts Q1 Loss Per Share Of $0.46 Vs. Loss $1.25 Year Ago
5/10/2013
|
|
|
-
Telik Posts Q4 Loss Per Share Of $0.66 Vs. Loss $1.38 Year Ago
3/15/2013
|
|
|
-
Telik Announces Preliminary Agreement On Design Of Phase 3 Registration Trial Of Telintra
1/22/2013
|
|
|
|
|
-
Telik Announces Orphan Designation Of Telintra For Treatment Of Myelodysplastic Syndrome
1/11/2013
|
-
Telik Posts Q3 Loss Per Share Of $0.78 Vs. Loss $1.58 Year Ago
11/9/2012
|
|
|